How Minimal Residual Disease Assessment Emerged as an Important Tool for Blood Cancers

Now, scientists can review exponentially more cells looking for remaining traces of cancer. This process is especially important for treating blood cancers such as lymphoma because these cancers are difficult to detect. Because lymphoma can grow and spread long before an individual notices any outward sign, imprecise MRD review methods can leave dangerous, damaged cells in the body.